Fibrocystic Change.
| Autor: | Bennett DL; Department of Breast Imaging, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, MO, USA. Electronic address: Debbie.bennett@wustl.edu., Buckley A; Department of Breast Imaging, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, MO, USA., Lee MV; Department of Breast Imaging, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, MO, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Radiologic clinics of North America [Radiol Clin North Am] 2024 Jul; Vol. 62 (4), pp. 581-592. Date of Electronic Publication: 2024 Mar 07. |
| DOI: | 10.1016/j.rcl.2023.12.008 |
| Abstrakt: | Fibrocystic changes are commonly seen in clinically symptomatic patients and during imaging workup of screening-detected findings. The term "fibrocystic changes" encompasses a broad spectrum of specific benign pathologic entities. Recognition of classically benign findings of fibrocystic changes, including cysts and layering calcifications, can prevent unnecessary follow-ups and biopsies. Imaging findings such as solid masses, nonlayering calcifications, and architectural distortion may require core needle biopsy for diagnosis. In these cases, understanding the varied appearances of fibrocystic change aids determination of radiologic-pathologic concordance. Management of fibrocystic change is typically conservative. Competing Interests: Disclosure The authors have nothing to disclose. (Copyright © 2024 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|